Echocardiographic epidemiology - An emerging tool for early diagnosis, studying pathophysiology, predicting prognosis, and testing treatments

European Heart Journal

Volumn 30, Issue 6, 2009, Pages 642-644

  Fraser, Alan G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; EDITORIAL; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING;

EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; HEART VENTRICLES; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 64949185356     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp067     Document Type: Editorial

References (14)

1. Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Schnohr P, Jensen JS. Tissue Doppler echocardiography in persons with hypertension, diabetes, or ischaemic heart disease: the Copenhagen City Heart Study. Eur Heart J 2009;30:731-739. First published on 27 January 2009. doi:10.1093/ eurheartj/ehn596.
2. Fraser AG, Payne N, Mädler CF, Janerot-Sjøberg B, Lind B, Grocott-Mason RM, lonescu AA, Florescu N, Wilkenshoff U, Lancellotti P, Wütte M, Brodin L-A. Feasibility and reproducibility of off-line tissue Doppler measurement of regional myocardial function during dobutamine stress echocardiography. Eur J Echo-cordiogr 2003;4:43-53.
3. Sanderson JE, Fraser AG. Systolic dysfunction in HFNEF (heart failure with normal left ventricular ejection fraction): echo-Doppler measurements. Prog Cordiovosc Dis 2006;49:196-206.
4. Vinereanu D, Nicolaides E, Tweddel AC, Mädler CF, Hoist B, Boden LE, Cinteza M, Rees JAE, Fraser AG. Subclinical left ventricular dysfunction in asymptomatic patients with type 2 diabetes mellitus, related to serum lipids and glycated haemoglobin. Clin Sci (Lond) 2003;105:591-599.
5. Przewlocka-Kosmala M, Kosmala W, Mazurek W. Left ventricular circumferential function in patients with essential hypertension. J Hum Hypertension 2006;20: 666-671.
6. Rietzschel ER, Langlois M, De Buyzere ML, Segers P, De Bacquer D, Bekaert S, Cooman L, Van Oostveldt P, Verndonck P, De Backer GG, Gillebert TC, for the Asklepios Investigators. Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations. Hypertension 2008;52:535-541.
7. Sharman JE, Haluska BA, Fang ZY, Prins JB, Marwick TH. Association of arterial wave properties and diastolic dysfunction in patients with type 2 diabetes mellitus. Am J Cardiol 2007;99:844-848.
8. Rakebrandt F, Palombo C, Swampillai J, Schön F, Donald A, Kozàkovà M, Kato K, Fraser AG. Arterial wave intensity and ventricular-arterial coupling by vascular ultrasound-rationale and methods for the automated analysis of forwards and backwards running waves. Ultrasound Med Biol 2009;35:266-277.
9. Yu CM, Sanderson JE, Marwick TH, Oh JK. Tissue Doppler imaging. A new prognostic indicator for cardiovascular diseases. J Am Coll Cordioi 2007;49:1903-1914.
10. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
11. Kuznetsova T, Herbots L, Richart T, D'hooge J, Thijs L, Fagard RH, Herrogods MC, Staessen JA. Left ventricular strain and strain rate in a general population. Eur Heart J 2008;29:2014-2023.
12. Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, Williams JW, Kunz R, Craig J, Montori VM, Bossuyt P, Guyatt GH; GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008;336:1106-1110.
13. Chan AKY, Sanderson JE, Wang T, Lam W, Yip G, Wang M, Lam YY, Zhang Y, Yeung L, Wu EB, Chan WWM, Wong JTH, So N, Yu CM. Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure, J Am Coll Cardiol 2007;50:591-596.
14. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JMO, Thomas JD, Zile MR, Aurigemma GP, for the Valsartan in Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihyper-tensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007;369:2079- 2087.